美國居民不適用 XM 服務。
M
M

McCormick


財經新聞

Tesla investors to urge judge to reject record $7 bln legal fee in Musk pay case

Tesla investors to urge judge to reject record $7 bln legal fee in Musk pay case By Tom Hals WILMINGTON, Delaware, July 8 (Reuters) - Tesla shareholders will appear in court on Monday to argue that an unprecedented request for more than $7 billion in attorneys' fees to be paid by the company is "outlandish," the latest twist in a legal showdown over Musk's $56 billion pay package.
T
D
M

U.S. Alphabet, Equity Residential, Infinera

U.S. RESEARCH ROUNDUP-Alphabet, Equity Residential, Infinera June 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alphabet, Equity Residential and Infinera, on Friday. HIGHLIGHTS * Alphabet Inc GOOGL.O : Rosenblatt Securities cuts to neutral from buy * American Financial Group Inc AFG.N : Citigroup cuts to neutral from buy * Cincinnati Financial Corp CINF.O : Citigroup raises to buy from neutral * Equity Residenti
A
A
A
C
C
C
G
G
H
N
P
W
D
P
C
A
G
H
L
M

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Super Micro Computer Inc SMCI.OQ +6.7% Palo Alto Networks Inc PANW.OQ +5.6% Arista Networks Inc ANET.N +4.2% Salesforce Inc CRM.N +4.1% McCormick & Company Inc MKC.N +3.7% Bottom Performers Percent Change Walgreens Boots Alliance Inc W
C
M
S
W
U
A
M

U.S. STOCKS Tempus AI, AeroVironment, Gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, AeroVironment, Gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were flat on Thursday, as investors assessed a string of economic data ahead of the Federal Reserve's closely watched inflation report, while Micron and pharmacy chain Walgreens Boots Alliance slumped on disappointing forecasts.
B
G
H
M
N
S
W
U
U
T
C
M

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Salesforce Inc CRM.N +5.3% Palo Alto Networks Inc PANW.OQ +4.4% McCormick & Company Inc MKC.N +4.2% Super Micro Computer Inc SMCI.OQ +3.8% Adobe Inc ADBE.OQ +3.4% Bottom Performers Percent Change Walgreens Boots Alliance Inc WBA.OQ -24
A
C
M
S
W
U
M

U.S. STOCKS Verona Pharma, McCormick, gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Verona Pharma, McCormick, gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq slightly fell while other indexes were flat to slightly higher on Thursday, as a dip in Treasury yields after a string of economic data boosted megacap stocks.
B
G
H
M
S
W
U
U
T
M

McCormick up after upbeat quarterly results on strong EMEA business

BUZZ-McCormick up after upbeat quarterly results on strong EMEA business ** Shares of hot sauce maker McCormick MKC.N up as much as 6.4% at $72 in early trading ** Stock snaps two sessions of losses, set for best day since March 2024 ** Co beats quarterly sales and profit estimates owing to strong demand for its spices and seasonings in Europe, Middle East and Africa (EMEA) ** Posts Q2 sales of $1.64 bln vs LSEG estimates of $1.63 bln ** Reports 5% rise in EMEA business of consumer segment, driv
M

Spice maker McCormick beats quarterly results on strong EMEA business

Spice maker McCormick beats quarterly results on strong EMEA business June 27 (Reuters) - McCormick MKC.N beat market expectations for second-quarter profit and sales on Thursday, led by strong demand for its spices and seasonings in Europe, Middle East and Africa. Customers grappling with still-high costs preferred cooking at home to dining out , improving volumes across the company's consumer segment, its biggest unit.
M

McCormick & Company Q2 Adjusted EPS USD 0.69 Vs. Estimate USD 0.61

BRIEF-McCormick & Company Q2 Adjusted EPS USD 0.69 Vs. Estimate USD 0.61 Jun 27 (Reuters) - McCormick & Company Q2 operating income USD 234 million. Q2 EPS USD 0.68 Q2 adjusted operating income USD 236 million vs. estimate USD 236.4 million outlook FY adjusted EPS USD 2.8-2.85 outlook FY EPS USD 2.76-2.81
M

Mccormick Announces Marcos Gabriel To Become Executive VP & CFO And Planned Retirement Of Mike Smith

BRIEF-Mccormick Announces Marcos Gabriel To Become Executive VP & CFO And Planned Retirement Of Mike Smith McCormick & Company Inc MKC.N : MCCORMICK ANNOUNCES MARCOS GABRIEL TO BECOME EXECUTIVE VP & CFO AND PLANNED RETIREMENT OF MIKE SMITH Source text for Eikon: ID:nPn9fBFz3a Further company coverage: MKC.N
M

McCormick names insider Marcos Gabriel as CFO

UPDATE 1-McCormick names insider Marcos Gabriel as CFO Adds details in paragraph 1 and 2 June 26 (Reuters) - Cholula hot sauce maker McCormick & Company MKC.N said on Wednesday it has named company insider Marcos Gabriel as its chief financial officer effective Dec. 1 . Current CFO Mike Smith, who has been at the designation since 2016, there on will continue with the company as Executive Vice President until his retirement on Feb.
M

McCormick & Company names insider Marcos Gabriel as CFO

McCormick & Company names insider Marcos Gabriel as CFO June 26 (Reuters) - McCormick & Company MKC.N said on Wednesday it has named company insider Marcos Gabriel as its chief financial officer. Reporting by Tanay Dhumal in Bengaluru; Editing by Alan Barona
M

What to Watch in the Day Ahead - Thursday, June 27

What to Watch in the Day Ahead - Thursday, June 27 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT On the U.S. economic calendar, the Commerce Department's Bureau of Economic Analysis is expected to report in its final estimate that the gross domestic product likely grew at 1.3% annualized rate
N
W
M

McCormick & Company Inc <MKC.N> expected to post earnings of 59 cents a share - Earnings Preview

McCormick & Company Inc expected to post earnings of 59 cents a share - Earnings Preview McCormick & Company Inc MKC.N , MKC is expected to show a fall in quarterly revenue when it reports results on June 27 for the period ending May 31 2024 The Hunt Valley Maryland-based company is expected to report a 1.7% decrease in revenue to $1.632 billion from $1.66 billion a year ago, according to the mean estimate from 11 analysts, based on LSEG data.
M

What to Watch in the Week Ahead and on Monday, June 24

What to Watch in the Week Ahead and on Monday, June 24 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT ON MONDAY Federal Reserve Bank of San Francisco President Mary Daly will likely speak on monetary policy and the economy at an event in partnership with the Commonwealth Club World Affairs of
N
T
W
M

U.S. earnings week ahead

DIARY-U.S. earnings week ahead June 21 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 25-Jun-2024 AMC FDX FedEx Corp Q4 2024 FedEx Corp Earnings Release 25-Jun-2024 AMC JNPR Juniper Networks Inc Q2 2024 Preliminary Juniper Networks Inc Earnings Release 26-Jun-2024 AMC MU.O Micron Technology Inc Q3 2024 Micron Technology Inc Ear
M
N
P
W
U
M

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
C
C
D
M

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
U
T
C
C
D
M

U.S. BioNTech, Honeywell International, Klaviyo

U.S. RESEARCH ROUNDUP-BioNTech, Honeywell International, Klaviyo June 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biontech, Honeywell International and Klaviyo, on Wednesday. HIGHLIGHTS * BioNTech SE BNTX.O : JP Morgan raises target price to $94 from $90 * Honeywell International Inc HON.O : HSBC raises target price to $235 from $200 * Klaviyo Inc KVYO.N : Barclays raises to overweight from equal weight * NetA
A
F
G
N
R
G
D
M

Mccormick Appoints Valarie Sheppard To Board Of Directors

BRIEF-Mccormick Appoints Valarie Sheppard To Board Of Directors May 21 (Reuters) - McCormick & Company Inc MKC.N : MCCORMICK APPOINTS VALARIE SHEPPARD TO BOARD OF DIRECTORS Source text for Eikon: ID:nPn3mWK4Za Further company coverage: MKC.N
M



細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明